| Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964) |
|---|
| 06/29/2006 | DE102004060229A1 Neue zyklische Harnstoffe als Inhibitoren von Metallproteasen New cyclic ureas as inhibitors of metalloproteases |
| 06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067508 Diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition |
| 06/22/2006 | WO2006064375A2 Aminoaryl substituted five-membered ring heterocyclic compounds for the treatment of diseases |
| 06/22/2006 | US20060135572 Compounds as for example, 2'-[1-[(2R)-3-[[1-(3-fluoro-4-methylphenyl)-2-methylpropan-2-yl]amino]-2-hydroxypropoxy]ethyl]-3-methylbiphenyl-4-carboxylic acid, having a calcium-sensing receptor antagonistic action; therapeutic drug for osteoporosis |
| 06/22/2006 | US20060135513 Methods of treating tumors |
| 06/22/2006 | US20060134724 Method and probe for identifying bacterial virulence modifying agents, agents thus identifed, and their use |
| 06/21/2006 | EP1671958A1 Method of producing amide compound |
| 06/21/2006 | EP1671957A1 Thiadiazoline derivatives |
| 06/21/2006 | EP1670772A1 Derivatives of 1,3-diones having a herbicidal activity |
| 06/21/2006 | CN1791585A Cyclic sulfonamides for inhibition of gamma-secretase. |
| 06/21/2006 | CN1791584A Process for preparing a 4,7-bis(5-halothien-2-yl)-2,1,3-benzothiadiazole and a precursor therefor |
| 06/21/2006 | CN1791572A Novel compounds |
| 06/20/2006 | US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/15/2006 | WO2006062224A1 Carboxamide derivative |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006047772A3 Tricyclic spacer systems for nonlinear optical devices |
| 06/15/2006 | WO2005085188A3 Compounds and methods for anti-tumor therapy |
| 06/15/2006 | US20060128948 obtained by modifying carboxyl groups of biological low-molecular-weight compounds having two or more carboxyl groups with N-hydroxysuccinimide, N-hydroxysulfosuccinimide; used to treat medical devices and the like are non-natural, artificially synthesized products; low toxicity and easily assimilated |
| 06/15/2006 | US20060128772 2-(2-methoxyphenyl)-3-(2-methoxy-phenyl)-5-phenylamino-(1,2,4)-thiadiazol-2 -ium; metabolic, nervous system and dermatological disorders, antidiabetic; obesity, impaired oral glucose tolerance, type II diabetes and Syndrome X, acne, dry skin and seborrheic dermatitis |
| 06/15/2006 | CA2590962A1 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
| 06/14/2006 | EP1668008A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use |
| 06/14/2006 | EP1667643A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 06/14/2006 | CN1785984A Organic electroluminous material and its application |
| 06/14/2006 | CN1785983A Benzo [1,2,3] thiadiazole derivative its synthesis method and use |
| 06/14/2006 | CN1785982A New benzothiazine and benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 06/14/2006 | CN1259321C Substituted benzene fused heterocycle herbicides |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | US7060718 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular |
| 06/13/2006 | CA2260777C Pentafluorobenzenesulfonamides and analogs |
| 06/08/2006 | US20060122173 Il-8 receptor antagonists |
| 06/07/2006 | EP1663237A2 Fused ring heterocycles as potassium channel modulators |
| 06/01/2006 | WO2006030211A3 Acyclic sulphonamides |
| 06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 06/01/2006 | CA2588607A1 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |
| 05/31/2006 | EP1661568A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661567A1 Compounds effecting Glucokinase |
| 05/31/2006 | EP1661563A1 Compound effecting Glucokinase |
| 05/31/2006 | EP1660441A2 N-sulfonyl-alpha-amino-acid derivatives |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1296931B1 Polyamine analogues as cytotoxic agents |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053220 For therapy and prophylaxis of neurological disorders associated with beta -amyloid peptide; Alzheimer's disease |
| 05/26/2006 | WO2006054652A1 Amide compound |
| 05/26/2006 | CA2584619A1 Amide compound |
| 05/26/2006 | CA2574535A1 Diuretic compounds comprising heterocyclic nitric oxide donor groups, compositions and methods of use |
| 05/25/2006 | US20060111406 Amide linker peroxisome proliferator activated receptor modulators |
| 05/25/2006 | US20060111359 enzyme inhibitor for treating sleep disorders |
| 05/25/2006 | US20060111353 2-Cyclohexyl-1-(4-methanesulfonyl-phenyl)-cyclopropanecarboxylic acid 5-chloro-thiazol-2-yl)-amide; antidiabetic agents; non-insulin dependent diabetes; disorders associated with GK dysfunction; an enhanced solubility profile; improved metabolic stability; increased insulin secretion |
| 05/25/2006 | US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases |
| 05/24/2006 | EP1658285A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | EP1658273A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | EP1658072A1 Compounds for the treatment of neurodegenerative disorders |
| 05/24/2006 | DE102004054847A1 Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 05/24/2006 | CN1777589A Heteroarylcarbamoylbenzene derivative |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/24/2006 | CN1775767A New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 05/23/2006 | US7049331 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | WO2006050830A1 Substituted benzoylguanidines method for production and use thereof as medicament or diagnostic and medicament comprising the same |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/17/2006 | EP1657954A1 Transmitter of wireless microphone, receiver for wireless microphone, mobile information communication apparatus, and communication system for wireless microphone |
| 05/17/2006 | CN1774428A M-stage kinesin inhibitor |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/11/2006 | WO2005012275A3 Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators |
| 05/11/2006 | DE4338348B4 2,6-Disubstituierte Benzotrifluoride 2,6-Disubstituted benzotrifluorides |
| 05/10/2006 | EP1655990A1 Wireless microphone communication system |
| 05/10/2006 | EP1655299A1 Benzothiadiazine derivatives, process of preparation thereof and pharmaceutical compositions containing them |
| 05/10/2006 | EP1655030A1 Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/10/2006 | EP1654241A1 Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof |
| 05/10/2006 | CN1769276A Benzothiadiazine derivatives, process of preparation thereof and pharmaceutical compositions containing them |
| 05/09/2006 | US7041825 Additive compound for curing halogenated polymers |
| 05/09/2006 | US7041690 Viricides; hepatitis virus infections |
| 05/09/2006 | US7041689 Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase |
| 05/09/2006 | US7041688 Alkynly-substituted spirocyclic sulfamides for the treatment of alzheimer's disease |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/04/2006 | WO2005097817A3 Process and reagents for oligonucleotide synthesis and purification |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094713 For therapy and prophylaxis of AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) flux |
| 05/04/2006 | US20060094712 N-(4-{[4-(2-fluoroethyl)-1,1-dioxido-3,4-dihydro-2H-1,2,4-benzothiadiazin-7-yl]oxy}benzyl)methanesulphonamide; modulating AMPA(alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) receptor |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | US20060093551 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers |
| 05/04/2006 | CA2584794A1 Tricyclic spacer systems for nonlinear optical devices |
| 05/03/2006 | EP1651626A1 Urea derivatives and their use as tyrosinkinase inhibitors |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1107951B8 Homo- or copolymeric material based on sulfonylimides possessing a polymerizable group |
| 05/03/2006 | CN1768047A Benzo[1,2,5]oxadiazoles and benzo [1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers. |
| 05/03/2006 | CA2524869A1 New benzothiadiazine derivatives, their preparation process and the pharmaceutical compounds that contain them |
| 05/03/2006 | CA2524859A1 New benzothiadiazine derivatives, their preparation process and the pharmaceutical compounds that contain them |